Free Trial

Waters (WAT) Competitors

Waters logo
$349.93 -2.48 (-0.70%)
As of 03:58 PM Eastern

WAT vs. A, MTD, ILMN, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMO

Should you be buying Waters stock or one of its competitors? The main competitors of Waters include Agilent Technologies (A), Mettler-Toledo International (MTD), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry.

Waters vs. Its Competitors

Agilent Technologies (NYSE:A) and Waters (NYSE:WAT) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment.

Waters has a net margin of 22.02% compared to Agilent Technologies' net margin of 17.59%. Waters' return on equity of 41.70% beat Agilent Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Agilent Technologies17.59% 25.92% 13.24%
Waters 22.02%41.70%15.67%

In the previous week, Waters had 28 more articles in the media than Agilent Technologies. MarketBeat recorded 45 mentions for Waters and 17 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.13 beat Waters' score of 0.25 indicating that Agilent Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agilent Technologies
12 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Waters
13 Very Positive mention(s)
6 Positive mention(s)
18 Neutral mention(s)
6 Negative mention(s)
1 Very Negative mention(s)
Neutral

Agilent Technologies has higher revenue and earnings than Waters. Agilent Technologies is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilent Technologies$6.51B5.15$1.29B$4.0529.15
Waters$2.96B7.04$637.83M$11.0231.75

Agilent Technologies has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500. Comparatively, Waters has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500.

94.0% of Waters shares are held by institutional investors. 0.8% of Waters shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Agilent Technologies currently has a consensus target price of $140.92, indicating a potential upside of 19.37%. Waters has a consensus target price of $388.00, indicating a potential upside of 10.88%. Given Agilent Technologies' higher probable upside, equities analysts plainly believe Agilent Technologies is more favorable than Waters.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilent Technologies
0 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.54
Waters
0 Sell rating(s)
9 Hold rating(s)
7 Buy rating(s)
2 Strong Buy rating(s)
2.61

Summary

Waters beats Agilent Technologies on 11 of the 16 factors compared between the two stocks.

Get Waters News Delivered to You Automatically

Sign up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WAT vs. The Competition

MetricWatersMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$20.82B$6.87B$5.46B$20.33B
Dividend YieldN/A1.04%5.36%3.78%
P/E Ratio31.7526.6326.4627.52
Price / Sales7.0475.93404.5438.36
Price / Cash23.3021.4025.8817.85
Price / Book11.364.757.924.54
Net Income$637.83M$171.62M$3.15B$985.09M
7 Day Performance2.04%1.78%2.20%1.70%
1 Month Performance0.37%-0.92%4.39%4.05%
1 Year Performance20.62%18.96%32.26%12.20%

Waters Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WAT
Waters
4.5183 of 5 stars
$349.93
-0.7%
$388.00
+10.9%
+21.4%$20.82B$2.96B31.758,200Trending News
A
Agilent Technologies
4.5938 of 5 stars
$116.21
+0.6%
$140.15
+20.6%
-8.0%$33.01B$6.51B28.6917,900Positive News
Analyst Upgrade
MTD
Mettler-Toledo International
4.6071 of 5 stars
$1,164.53
+0.9%
$1,302.11
+11.8%
-15.3%$24.20B$3.87B29.0417,300Positive News
ILMN
Illumina
4.8468 of 5 stars
$90.61
+0.1%
$126.94
+40.1%
-9.2%$14.34B$4.34B-14.939,030Positive News
TECH
Bio-Techne
4.9748 of 5 stars
$49.30
-1.2%
$72.00
+46.0%
-27.6%$7.73B$1.16B60.123,100Positive News
CRL
Charles River Laboratories International
4.4464 of 5 stars
$147.41
0.0%
$171.85
+16.6%
-27.4%$7.24B$4.05B-226.7920,100Analyst Downgrade
BIO
Bio-Rad Laboratories
4.8942 of 5 stars
$235.92
-0.3%
$324.25
+37.4%
-10.7%$6.42B$2.57B-3.107,700Positive News
BRKR
Bruker
4.9053 of 5 stars
$38.73
+1.7%
$56.22
+45.2%
-34.5%$5.87B$3.37B74.4811,396
PACB
Pacific Biosciences of California
2.1379 of 5 stars
$1.19
-6.3%
$2.13
+79.1%
-5.8%$357.10M$154.01M-0.43730
HBIO
Harvard Bioscience
4.1906 of 5 stars
$0.51
-3.4%
$3.00
+484.0%
-83.9%$22.71M$94.14M-0.39490Trending News
TMO
Thermo Fisher Scientific
4.9926 of 5 stars
$400.26
+0.6%
$605.30
+51.2%
-26.3%$151.09B$42.88B23.48125,000Positive News

Related Companies and Tools


This page (NYSE:WAT) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners